Q3 EPS Estimates for Henry Schein Cut by Barrington Research

Henry Schein, Inc. (NASDAQ:HSIC) – Stock analysts at Barrington Research decreased their Q3 2025 earnings per share (EPS) estimates for shares of Henry Schein in a note issued to investors on Tuesday, May 6th. Barrington Research analyst M. Petusky now forecasts that the company will earn $1.25 per share for the quarter, down from their previous forecast of $1.30. Barrington Research currently has a “Outperform” rating and a $86.00 target price on the stock. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. Barrington Research also issued estimates for Henry Schein’s FY2025 earnings at $4.85 EPS.

Other equities research analysts have also recently issued reports about the company. Piper Sandler dropped their price objective on Henry Schein from $83.00 to $77.00 and set an “overweight” rating for the company in a research note on Wednesday, April 30th. Jefferies Financial Group lifted their target price on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research report on Thursday, January 23rd. Wells Fargo & Company reduced their price target on shares of Henry Schein from $80.00 to $75.00 and set an “equal weight” rating on the stock in a research report on Tuesday, May 6th. UBS Group dropped their price objective on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a report on Wednesday, February 26th. Finally, StockNews.com lowered shares of Henry Schein from a “buy” rating to a “hold” rating in a report on Thursday, April 17th. Six investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $79.30.

Henry Schein Stock Down 0.3 %

Henry Schein stock opened at $68.68 on Friday. The company has a market capitalization of $8.41 billion, a PE ratio of 28.26, a price-to-earnings-growth ratio of 2.13 and a beta of 0.87. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein has a fifty-two week low of $60.56 and a fifty-two week high of $82.49. The firm has a 50 day moving average price of $67.59 and a 200 day moving average price of $71.45.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.04. The company had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein’s revenue was down .1% compared to the same quarter last year. During the same quarter last year, the firm posted $1.10 earnings per share.

Institutional Investors Weigh In On Henry Schein

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Smartleaf Asset Management LLC grew its holdings in shares of Henry Schein by 23.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock worth $52,000 after purchasing an additional 143 shares during the last quarter. Guggenheim Capital LLC grew its stake in Henry Schein by 2.5% during the 4th quarter. Guggenheim Capital LLC now owns 6,428 shares of the company’s stock worth $445,000 after buying an additional 159 shares during the last quarter. CIBC Asset Management Inc increased its position in Henry Schein by 1.0% during the fourth quarter. CIBC Asset Management Inc now owns 17,849 shares of the company’s stock worth $1,235,000 after buying an additional 169 shares during the period. Metis Global Partners LLC lifted its stake in Henry Schein by 4.7% in the fourth quarter. Metis Global Partners LLC now owns 4,203 shares of the company’s stock valued at $291,000 after buying an additional 187 shares during the last quarter. Finally, UMB Bank n.a. boosted its holdings in shares of Henry Schein by 23.2% in the first quarter. UMB Bank n.a. now owns 1,066 shares of the company’s stock valued at $73,000 after acquiring an additional 201 shares during the period. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Henry Schein

In other Henry Schein news, Director Philip A. Laskawy sold 2,604 shares of the firm’s stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the sale, the director now owns 24,805 shares of the company’s stock, valued at approximately $1,762,147.20. This trade represents a 9.50 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Bradford C. Connett sold 4,036 shares of the company’s stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the transaction, the chief executive officer now owns 62,688 shares of the company’s stock, valued at approximately $4,460,251.20. The trade was a 6.05 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.08% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.